Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.7 INR | +2.93% | -3.58% | +63.90% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 55.56 | 35.8 | 25.76 | 38.08 | 42.07 | 56.01 |
Enterprise Value (EV) 1 | 50.61 | 29.3 | 16.37 | 36.37 | 37.81 | 55.91 |
P/E ratio | 21 x | 11.9 x | 8.33 x | 37 x | 16.8 x | 19.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.49 x | 0.31 x | 0.24 x | 0.38 x | 0.3 x | 0.43 x |
EV / Revenue | 0.45 x | 0.26 x | 0.15 x | 0.37 x | 0.27 x | 0.42 x |
EV / EBITDA | 14 x | 8.93 x | 3.54 x | 11.3 x | 11.3 x | 12.7 x |
EV / FCF | 37.8 x | -15.7 x | 10.8 x | -4.42 x | 41.8 x | -11.1 x |
FCF Yield | 2.65% | -6.35% | 9.24% | -22.6% | 2.39% | -8.97% |
Price to Book | 4.61 x | 2.38 x | 1.42 x | 1.99 x | 1.94 x | 2.28 x |
Nbr of stocks (in thousands) | 4,481 | 4,481 | 4,481 | 4,481 | 4,481 | 4,481 |
Reference price 2 | 12.40 | 7.990 | 5.750 | 8.500 | 9.390 | 12.50 |
Announcement Date | 8/6/18 | 8/2/19 | 8/19/20 | 7/28/21 | 7/28/22 | 7/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 113 | 114.5 | 108.1 | 99.62 | 141.8 | 131.6 |
EBITDA 1 | 3.626 | 3.28 | 4.63 | 3.213 | 3.351 | 4.386 |
EBIT 1 | 2.621 | 2.416 | 3.84 | 2.4 | 2.587 | 3.621 |
Operating Margin | 2.32% | 2.11% | 3.55% | 2.41% | 1.82% | 2.75% |
Earnings before Tax (EBT) 1 | 2.626 | 3.003 | 3.084 | 1.035 | 2.996 | 3.296 |
Net income 1 | 2.626 | 3.003 | 3.084 | 1.035 | 2.525 | 2.825 |
Net margin | 2.32% | 2.62% | 2.85% | 1.04% | 1.78% | 2.15% |
EPS 2 | 0.5900 | 0.6700 | 0.6900 | 0.2300 | 0.5600 | 0.6300 |
Free Cash Flow 1 | 1.339 | -1.862 | 1.513 | -8.23 | 0.904 | -5.016 |
FCF margin | 1.19% | -1.63% | 1.4% | -8.26% | 0.64% | -3.81% |
FCF Conversion (EBITDA) | 36.93% | - | 32.67% | - | 26.98% | - |
FCF Conversion (Net income) | 50.99% | - | 49.05% | - | 35.81% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/6/18 | 8/2/19 | 8/19/20 | 7/28/21 | 7/28/22 | 7/31/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 4.95 | 6.5 | 9.39 | 1.71 | 4.26 | 0.1 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 1.34 | -1.86 | 1.51 | -8.23 | 0.9 | -5.02 |
ROE (net income / shareholders' equity) | 24.4% | 22.1% | 18.6% | 5.55% | 12.3% | 12.2% |
ROA (Net income/ Total Assets) | 4.24% | 3.97% | 6.51% | 4.14% | 4.63% | 6.59% |
Assets 1 | 61.99 | 75.66 | 47.35 | 24.99 | 54.5 | 42.84 |
Book Value Per Share 2 | 2.690 | 3.360 | 4.050 | 4.280 | 4.850 | 5.480 |
Cash Flow per Share 2 | 1.100 | 1.450 | 2.100 | 0.3800 | 0.9500 | 0.0200 |
Capex | - | - | 1.03 | 0.65 | 0.21 | 1.02 |
Capex / Sales | - | - | 0.96% | 0.65% | 0.15% | 0.77% |
Announcement Date | 8/6/18 | 8/2/19 | 8/19/20 | 7/28/21 | 7/28/22 | 7/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- UNJHAFOR6 Stock
- Financials Unjha Formulations Limited